Your Messages Inbox
Your Article Summary
See Latest ArticlesGenmab achieves milestone in arzerra collaboration
Genmab, 10/27/09
Genmab A/S announced it has reached a milestone for Arzerra under the terms of its collaboration with GlaxoSmithKline. A milestone payment of approximately DKK 116 million was triggered by the FDA approval of Arzerra for the treatment of patients with chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/24/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/24/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Article Search
Sponsor